Hindustan Unilever Limited has informed the Exchange regarding Board meeting held on February 12, 2026.
HINDUNILVR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HUL's Board approved its Q3 FY26 (quarter ended 31 Dec 2025) results. Consolidated sales from continuing operations rose 6% to Rs. 16,235 crores, while EBITDA grew 3% to Rs. 3,788 crores with margin compressing 70 bps to 23.3%. Profit after tax from continuing operations fell 30% YoY to Rs. 2,118 crores, but reported PAT jumped 121% to Rs. 6,603 crores, driven by a one-time exceptional gain of Rs. 4,611 crores from the demerger of its ice cream business into Kwality Wall's (India) Limited, effective 1 Dec 2025. Standalone sales grew 4% to Rs. 15,614 crores, with EBITDA margin down 50 bps to 23.3%. The Board also approved acquiring the remaining 49% stake in Zywie Ventures and divesting its stake in Nutritionalab. Statutory auditors Walker Chandiok & Co LLP issued an unmodified review report.
Underlying business momentum is modest with single-digit sales growth and margin compression, but reported earnings are flattered by a large non-recurring demerger gain. Investors should focus on continuing-operations PAT (down 30%) and shrinking EBITDA margins as a more accurate read on core performance, while the demerger sharpens HUL's portfolio focus on higher-growth segments.